MomMoodBooster Web-Based Intervention for Postpartum Depression: Feasibility Trial Results

• Main Authors: Danaher, Brian G, Milgrom, Jeannette, Seeley, John R, Stuart, Scott, Schembri, Charlene, Tyler, Milagra S, Ericksen, Jennifer, Lester, Whitney, Gemmill, Alan W, Kosty, Derek B, Lewinsohn, Peter
• Format: Article
• Language: English
• Published: JMIR Publications 2013-11-01
• Series: Journal of Medical Internet Research
• Online Access: http://www.jmir.org/2013/11/e242/

BackgroundPostpartum depression (PPD)—the most common complication of childbirth—is a significant and prevalent public health problem that severely disrupts family interactions and can result in serious lasting consequences to the health of women and the healthy development of infants. These consequences increase in severity when left untreated; most women with PPD do not obtain help due to a range of logistical and attitudinal barriers. ObjectiveThis pilot study was designed to test the feasibility, acceptability, and potential efficacy of an innovative and interactive guided Web-based intervention for postpartum depression, MomMoodBooster (MMB). MethodsA sample of 53 women who satisfied eligibility criteria (<9 months postpartum, ≥18 years of age, home Internet access and use of personal email, Edinburgh Postnatal Depression Survey score of 12-20 or Patient Health Questionnaire score from 10-19) were invited to use the MMB program. Assessments occurred at screening/pretest, posttest (3 months following enrollment), and at 6 months follow-up. ResultsAll six sessions of the program were completed by 87% (46/53) of participants. Participants were engaged with the program: visit days (mean 15.2, SD 8.7), number of visits (mean 20.1, SD 12.2), total duration of visits in hours (mean 5.1, SD 1.3), and number of sessions viewed out of six (mean 5.6, SD 1.3) all support high usage. Posttest data were collected from 89% of participants (47/53) and 6-month follow-up data were collected from 87% of participants (46/53). At pretest, 55% (29/53) of participants met PHQ-9 criteria for minor or major depression. At posttest, 90% (26/29) no longer met criteria. ConclusionsThese findings support the expanded use and additional testing of the MMB program, including its implementation in a range of clinical and public health settings. Trial RegistrationClinicaltrials.gov NCT00942721; http://clinicaltrials.gov/ct2/show/NCT00942721 (Archived by WebCite at http://www.webcitation.org/6KjYDvYkQ).